Article
AstraZeneca's Imfinzi plus chemoradiotherapy fail main goal of late stage trial
Rating:
0.0
Views:
37
Likes:
1
Library:
1
Drugmaker AstraZeneca said on Tuesday its cancer drug Imfinzi given along with chemoradiotherapy (CRT) failed to meet its main goal in a late-stage trial to treat unresectable, Stage 3 non-small cell lung cancer.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value